Biotech

Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.

Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, announced an agreement with Tokyo-based SCRUM Inc. to expand its presence in Japan’s research community. This collaboration will provide researchers in academia and industry with full access to Parse’s innovative single cell sequencing solutions. “Biotech, pharma, and academic researchers throughout Asia are rapidly adopting Parse’s Evercode single cell sequencing solutions because of their scalability and simplicity,” said Alex Rosenberg, PhD, CEO and co-founder of Parse Biosciences. “By partnering with SCRUM, we are ensuring that researchers in Japan can easily leverage Parse’s advanced single cell sequencing technology to accelerate their discoveries.” Through this agreement, SCRUM will distribute Parse’s comprehensive portfolio of single cell solutions throughout Japan, including: Evercode™ Cell and Nuclei Fixation Evercode™ Whole Transcriptome Evercode™ TCR Evercode™…

Just for You

Otsuka Shokai provides operational support services for the EDR product “Microsoft Defender for Business”

Otsuka Shokai Co. Ltd. announced that it will start offering "Tayoreru EDR Advisory Service for…

Telexistence Inc. Joined the AI ​​Robot Association together with Toyota Motor Corporation and others to promote the construction of the VLA model

Telexistence Inc. has joined the AI ​​Robot Association as a board member and has begun…

ITBusinessToday Weekly News Roundup With Plus, ServiceNow, Chubu Electric Power, Rakus, NetOns & Airx and More!

In GovTech news this week… 🔹 Plus and TIER IV Partner to Advance Autonomy 2.0…

AWS Unveils “Ocelot” Quantum Chip, Advancing Error Correction with Analog Cat Qubits

Amazon Web Services (AWS) has launched its new quantum computing chip, "Ocelot." This move puts…

Latest Biotech

Boehringer Ingelheim Launches ‘One Medicine Platform’ with Veeva Cloud Integration

Veeva Systems announced that Boehringer Ingelheim has launched its own drug discovery platform, "One Medicine Platform," through the successful implementation…

Guardant Health & ConcertAI Launch Data Service for Cancer R&D

Guardant Health, Inc., a leading precision oncology company, and ConcertAI, a leading oncology real-world evidence data and AI SaaS technology…

Primo Partners with SHINE to Advance Precision Oncology in Asia Pacific

Primo Biotechnology ("Primo") has announced a strategic collaboration with SHINE Technologies ("Shine"), a global leader in nuclear medicine manufacturing. The…

CN Bio Partners with Primetech to Establish Distribution Channel for OOC Solutions in Japan

CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, announced it…

Daiichi Sankyo Acquires Anti-TA-MUC1 Antibody IP from Glycotope

Daiichi Sankyo Company, Ltd  announced  that it will pay Glycotope $132.5 million to acquire intellectual property rights of the anti-tumor-associated…

Join Our Community